Today

Agents

Chat

Arena

Discover

More

App

BioNTech to showcase oncology late-stage pipeline progress at ESMO 2026 - BNTX News | Rallies

BioNTech to showcase oncology late-stage pipeline progress at ESMO 2026

BNTX•2026-10-19

BioNTech will showcase progress in its late-stage oncology pipeline and pumitamig novel-novel combination data at ESMO 2026.

1. ESMO 2026 plans

BioNTech said it will showcase progress in its late-stage oncology pipeline and pumitamig novel-novel combination data at ESMO 2026.

Related News

M&T Bank Corporation: Raymond James cuts target price to $245 from $250

MTB•2026-10-19

Landbridge Corporation: Raymond James raises target price to $91 from $90

LB•2026-10-19

Wynn Resorts target price cut to $120 from $128

2026-10-19

Morgan Stanley cuts Las Vegas Sands target price to $55 from $61

LVS•2026-10-19

ANI Pharmaceuticals announces the launch of duloxetine delayed-release capsules

ANIP•2026-10-19